Gilead Sciences
GILD
#81
Rank
NZ$368.74 B
Marketcap
NZ$297.30
Share price
-0.41%
Change (1 day)
41.59%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): -NZ$3.72 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$30.45 Billion. In 2025 the company made an earning of NZ$17.45 Billion, an increase over its 2024 earnings that were of NZ$1.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$3.72 Billion-121.29%
2025 NZ$17.45 B1319.86%
2024 NZ$1.22 B-89.94%
2023 NZ$12.21 B17.97%
2022 NZ$10.35 B-29.77%
2021 NZ$14.74 B395.99%
2020 NZ$2.97 B-67.66%
2019 NZ$9.19 B-33.84%
2018 NZ$13.89 B-42.35%
2017 NZ$24.10 B-20.87%
2016 NZ$30.45 B-21.06%
2015 NZ$38.58 B45.8%
2014 NZ$26.46 B253.01%
2013 NZ$7.49 B16.51%
2012 NZ$6.43 B-1.07%
2011 NZ$6.50 B-6.71%
2010 NZ$6.97 B11.75%
2009 NZ$6.23 B29.5%
2008 NZ$4.81 B19.11%
2007 NZ$4.04 B-455.74%
2006 -NZ$1.14 Billion-154.93%
2005 NZ$2.06 B76.99%
2004 NZ$1.16 B-266.16%
2003 -NZ$0.71 Billion-638.24%
2002 NZ$0.13 B31.5%
2001 NZ$99.43 M-242.15%
2000 -NZ$69.96 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$88.72 Million8.73%
1997 -NZ$81.59 Million27.22%
1996 -NZ$64.14 Million
1994 -NZ$61.11 Million26.57%
1993 -NZ$48.28 Million46.49%
1992 -NZ$32.96 Million362.5%
1991 -NZ$7.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.34 B-1,057.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.30 B-453.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$15.49 B-544.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$61.93 B-1,878.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.32 B-626.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$1.80 B-151.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.06 B-159.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.98 B-358.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.69 B-493.35%๐Ÿ‡บ๐Ÿ‡ธ USA